SPARC Statement on Public Access Provisions in the U.S. Innovation and Competition Act – SPARC

“We are pleased to see the U.S. Senate endorse language that strongly supports providing faster access to taxpayer-funded research results with today’s passage of the U.S. Innovation and Competition Act (S. 1260). 

Section 2527 of the bill, formerly the Endless Frontier Act, (titled “Basic Research”) includes language originally written by Senator Wyden and supported by Senator Paul that directs federal agencies funding more than $100 million annually in research grants to develop a policy that provides for free online public access to federally-funded research “not later than 12 months after publication in peer-reviewed journals, preferably sooner.” 

The bill also provides important guidance that will maximize the impact of federally-funded research by ensuring that final author manuscripts reporting on taxpayer funded research are:

Deposited into federally designated or maintained repositories;
Made available in open and machine readable formats; 
Made available under licenses that enable productive reuse and computational analysis; and
Housed in repositories that ensure interoperability and long-term preservation. …”

All publishers must fully respect researchers’ rights by providing clarity and transparency on Open Access

“We are especially concerned by the unclear and opaque communication and practices of some publishers as reported by cOAlition S. Such an approach complicates and confuses matters for researchers, impeding progress towards a scholarly communication system based on Open Access to research outputs. We urge those publishers to reconsider their position and modernise, ensuring they play their part in providing fair and transparent conditions for authors. These should fully respect researchers’ rights, including the right to share their peer-reviewed research findings without restrictions or embargoes. If a publisher or platform chooses to take the stance of requiring authors to sign away their rights, they should clearly and publicly state this to ensure that researchers make informed choices. More broadly, the standard position of platforms and publishers should be to empower researchers to publish their findings (including data and digital assets) while retaining their rights. Researchers who wish to deposit their author-accepted manuscript in a repository with an open license (e.g. CC BY), and without any embargo, must be able to do so….”

JAMA Publishes Trial Results Delayed 5 Years. Here’s Why

“A treatment for shortening the painful episodes of sickle cell disease (SCD) is not effective, results published in JAMA indicate. But the effort it took to publish the findings is an important part of the story and reveal problems with data ownership, company motivations, and public resources that go well beyond a single clinical trial or experimental agent….”

Rights, sharing, and embargo policies

“Cell Press supports responsible sharing. We recognize that authors want to share their papers and we encourage this. Find out how you can share your paper here: www.elsevier.com/sharing-articles .

(opens in a new window)

There are, however, some differences between Elsevier’s general policies and those of Cell Press. Most Cell Press articles are under a press embargo until the article is published because we generate substantial media coverage for relevant articles….

We are happy to consider manuscripts previously posted on preprint servers such as arXiv(opens in a new window), bioRxiv(opens in a new window), BioRN(opens in a new window), ChiRxiv(opens in a new window), ChiRN(opens in a new window), or SSRN(opens in a new window). Some of our journals, including Cell Genomics, Cell Reports, Current Biology, and iScience, also support direct submission of manuscripts from bioRxiv and/or medRxiv via transfer of manuscript files and metadata to the journal’s Editorial Manager site. Our support for posting of preprints only applies to the original submitted version of the manuscript; we do not support posting to preprint servers revisions that respond to editorial input and peer review or final accepted manuscripts….

For authors submitting from January 2021 onwards all Cell Press journals offer an open access publishing option. We have a range of journals that are either full open access, where all articles are published on an open access basis, or hybrid open access, which offer a choice between subscription and open access publishing.

Authors of papers published by Cell Press can share their accepted manuscript (the post-peer-review version that does not incorporate copy editing and proofing) via non-commercial hosting platforms, such as their institutional repository, after a posting embargo period has elapsed (this is distinct from the press embargo mentioned above)….

Cell Press open access and hybrid research journals support open access publication for groups of authors from Research4Life (R4L) countries. For papers where all of the authors are from a Group A and/or Group B R4L country we will grant a waiver or discount of the standard publishing fee, as appropriate. For fully open access journals the R4L eligibility check will be automatic. For hybrid journals please highlight your situation to the journal team during the submission process so we can adjust accordingly….”

Health research council moves to mandate immediate open access – Research Professional News

“Australia’s National Health and Medical Research Council has proposed that immediate open-access publication of research resulting from its grants should become mandatory.

The council already requires researchers to list their patents on the government’s SourceIP website, but its existing policy allows a 12-month delay to open-access publication of NHMRC-funded research.

The proposed reforms would involve researchers publishing in open repositories, circumventing publishers’ fees, as well as publishing in traditional journals. Authors would be required to retain the rights to publish and share their work. It would also encourage researchers to release non-peer-reviewed preprints.

The proposals are contained in a discussion paper released by the council in April and would take effect from the beginning of 2022….”

Open Access Policy | NHMRC

“NHMRC supports the sharing of outputs from NHMRC funded research including publications and data. The aims of the NHMRC Open Access Policy are to mandate the open access sharing of publications and encourage innovative open access to research data. This policy also requires that patents resulting from NHMRC funding be made findable through listing in SourceIP….

NHMRC is seeking input from relevant stakeholders about proposed revisions to the Open Access Policy and Further Guidance. The proposed revisions are limited to sections of the documents about publications….”

Continuing the open access transition in 2021 and beyond | Advancing Discovery | Springer Nature

“However, for those of us committed to accelerating the transition to immediate gold OA, 2021 has come with a new challenge – the introduction by cOAlition S of its Rights Retention Strategy (RRS) and its  determination that zero-embargo green OA be used as an alternative to gold OA.  As we have made clear from the outset in our Plan S submission and contributions to blogs and letters, seeking to assert a prior CC BY licence on the accepted manuscript (AM) version of an article risks undermining the transition to immediate open access to the version of record, a goal we had thought cOAlition S shared with us.  This RRS/zero-embargo green OA approach forces publishers into defending subscription income since this is the only income available to pay for their per article costs. Further, this RRS/zero-embargo green OA approach has introduced significant confusion for authors with the priority it gives zero embargo green OA even if a journal provides a compliant immediate OA option for the version of record….”

#Zero Embargo Campaign – Are You With Us? | LIBER Europe

While the COVID-19 pandemic has surfaced the virtues of Open Access and propelled changes in scholarly communication that previously many feared, the current models of communicating scientific content still maintain unequal access to content.

On the other side of this highly regulated and controlled system, advocates of Open Access are exploring lawful ways to enable researchers to freely disseminate their research and maximize its impact.

The Rights Retention Strategy of PlanS (cOAlitionS) is a much-welcomed initiative that empowers authors to be in control of their own research and the granting schemes of HorizonEurope is another bold move by the European Commission in the same direction. It is now time that policies like these are implemented in all EU Member States and that the countries themselves have the same coordinated and horizontal approach.

Therefore, LIBER proposes a new model law that aims to ensure a zero embargo period for lawful self-archiving on open, public, non-for-profit repositories.

cOAlition S and repositories (part III) | Plan S

“From 1st January 2021, the cOAlition S Rights Retention Strategy (RRS) will start to be implemented by funders. A key reason for adopting this initiative is to allow authors to have the widest possible range of journals to choose from for article submission and to make sure they take advantage of the benefits of OA, whilst meeting their funder’s OA requirements. The RRS is not principally about compliance – OA should never primarily be about box-ticking and compliance – it is about restoring intellectual control of works describing research findings to the authors themselves. Adoption of the RRS gives authors the security that acceptance of their article for submission ensures that they can eventually make their work OA either via the Version of Record (VoR), or the author accepted manuscript (AAM), independently of the choice of venue (fully OA or subscription journal).

The RRS cuts through much of the confusion, obfuscation, and – to be frank – utter nonsense surrounding copyright transfer claims made by some publishers.